You searched for "pharmaceuticals"
Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity
5 June 2023
| Rod McNeil
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...
The Moorfields and UCL Laser course for ophthalmologists
6 November 2024
Moorfields Eye Hospital and UCL Institute of Ophthalmology are delighted to present this new laser course for ophthalmologists. This full day course will be delivered by Moorfields consultants and senior clinicians. It is designed to enhance both theoretical knowledge and...
Moorfields corneal suturing and penetrating keratoplasty wet lab
17 January 2025
Corneal suturing is an essential skill for all ophthalmologists, but with reduced training opportunities is becoming increasingly difficult to master.The Moorfield’s corneal suturing and penetrating keratoplasty course, delivered by corneal surgeons at Moorfields, will provide hands on experience in corneal...
Scope Eyecare joins ABDO National Resource Centre as a new gold digital sponsor
The ABDO National Resource Centre (NRC) based in Birmingham has secured a new gold digital sponsor in Scope Eyecare. Scope Eyecare a leading healthcare and pharmaceuticals company specialising in ophthalmic and general health solutions, is proud to announce its sponsorship...Moorfields Education: myopia control in children
13 November 2024
This full day, online course will deliver a range of lectures from various experts involved in research and treatment of children with myopia. We will be covering myopia epidemiology, risk factors and causes, progression of myopia, current research and evidence,...
Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?
Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...Congratulations to the SOC poster prize winners!
24 September 2021
The Scottish Ophthalmological Club (SOC) recently hosted another excellent webinar on the theme ‘Post COVID – The Best of Times and The Worst of Times'.
Moorfields DALK wet lab
27 June 2025
Deep Anterior Lamellar Keratoplasty (DALK) is the most challenging technique of corneal transplantation. Moorfields Eye Hospital performs a high volume of DALK surgeries and is currently the leading centre in corneal transplantation in Europe. The Moorfields DALK wet lab, delivered...
Experiences of patients and their families and the impact of Leber hereditary optic neuropathy
3 April 2023
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a qualitative study which aimed to explore the impact of Leber hereditary optic neuropathy (LHON) from diagnosis to present day on both patients and their families. Individuals with LHON and their families were purposively sampled from four...
Retina UK Annual Conference 2025
20 September 2025
The Retina UK Conference is an excellent opportunity to find out the latest news from Retina UK, hear from expert speakers, meet other members of our community and to make new connections. The line-up for their 50th anniversary year conference...
EU: is it time to leave and embrace the world?
1 June 2016
| Rod McNeil
|
EYE - General
Should the United Kingdom remain a member of the European Union (EU) or leave? It’s a big decision involving some complex issues, and there’s no doubt the EU will continue to change. Ipsos MORI’s monthly EU voting intention poll published...
Rayner announces acquisition of Sophi
17 January 2024
|
Contracts & Distributors, Company Profiles
Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.
